| Literature DB >> 31510079 |
Duc Danh Cao1,2, Thi Thanh Van Trinh1, Huong Doan Thi Mai1,2, Van Nam Vu1, Hong Minh Le1, Quyen Vu Thi1, Mai Anh Nguyen1, Thu Trang Duong1, Dang Thach Tran3, Van Minh Chau1, Rui Ma4, Gauri Shetye4, Sanghyun Cho4, Brian T Murphy5, Van Cuong Pham6.
Abstract
Three new lavandulylated flavonoids, (2S,2''S)-6-lavandulyl-7,4'-dimethoxy-5,2'-dihydroxylflavanone (1), (2S,2''S)-6-lavandulyl-5,7,2',4'-tetrahydroxylflavanone (2), and (2''S)-5'-lavandulyl-2'-methoxy-2,4,4',6'-tetrahydroxylchalcone (3), along with seven known compounds 4-10 were isolated from culture broth of Streptomyces sp. G248. Their structures were established by spectroscopic data analysis, including 1D and 2D nuclear magnetic resonance (NMR), and high-resolution electrospray ionization mass spectrometry (HR-ESI-MS). The absolute configurations of 1-3 were resolved by comparison of their experimental and calculated electronic circular dichroism spectra. Compounds 1-3 exhibited remarkable antimicrobial activity. Whereas, two known compounds 4 and 5 exhibited inhibitory activity against Mycobacterium tuberculosis H37Rv with minimum inhibitory concentration (MIC) values of 6.0 µg/mL and 11.1 µg/mL, respectively.Entities:
Keywords: Streptomyces; actinomycete; anti-microbial; anti-tuberculosis; cytotoxicity; flavonoid
Mesh:
Substances:
Year: 2019 PMID: 31510079 PMCID: PMC6780759 DOI: 10.3390/md17090529
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of compounds 1–10.
NMR data for compounds 1–3 (CD3OD, 1H: 500 MHz, 13C: 125 MHz).
| 1 | 2 | 3 | ||||
|---|---|---|---|---|---|---|
| N | δC | δH mult. ( | δC | δH mult. ( | δC | δH mult. ( |
| 1 | - | - | - | - | 116.3 | - |
| 2 | 75.0 | 5.55 dd (2.5, 13.5) | 75.8 | 5.58 dd (3.0, 13.0) | 160.3 | - |
| 3 | 45.4 | 2.89 dd (13.5, 17.0) | 43.3 | 2.99 dd (13.0, 17.0) | 103.7 | 6.35 br.s |
| 4 | 193.6 | - | 198.9 | - | 162.4 | - |
| 5 | 164.7 | - | 162.6 | - | 109.0 | 6.36 dd (2.0, 8.0) |
| 6 | 109.6 | - | 108.7 | - | 131.6 | 7.41 d (8.0) |
| 7 | 165.4 | - | 167.0 | - | - | - |
| 8 | 93.6 | 6.12 s | 96.4 | 5.93 s | - | - |
| 9 | 161.9 | - | 163.2 | - | - | - |
| 10 | 105.7 | - | 103.2 | - | - | - |
| 1′ | 119.7 | - | 118.4 | - | 106.5 | - |
| 2′ | 160.1 | - | 156.7 | - | 162.3 | - |
| 3′ | 99.8 | 6.49 d (2.3) | 103.4 | 6.36 d (2.5) | 91.6 | 6.02 s |
| 4′ | 159.0 | - | 159.6 | - | 164.1 | - |
| 5′ | 108.1 | 6.47 dd (2.3, 8.5) | 107.7 | 6.37 dd (2.0, 8.5) | 108.9 | - |
| 6′ | 128.5 | 7.38 d (8.5) | 128.6 | 7.32 d (8.5) | 166.6 | - |
| 1″ | 28.2 | 2.63 m | 28.0 | 2.60 m | 28.2 | 2.65 m |
| 2″ | 48.2 | 2.50 m | 48.4 | 2.49 m | 48.0 | 2.57 m |
| 3″ | 32.3 | 2.02 m | 32.3 | 2.01 m | 32.4 | 2.09 m |
| 4″ | 124.8 | 4.96 t (5.5) | 124.8 | 4.99 t (5.5) | 125.0 | 5.06 td (1.0, 6.5) |
| 5″ | 132.0 | - | 132.0 | - | 131.8 | - |
| 6″ | 17.8 | 1.48 s | 17.8 | 1.50 s | 17.9 | 1.58 s |
| 7″ | 25.8 | 1.57 s | 25.8 | 1.59 s | 25.9 | 1.65 s |
| 8″ | 149.8 | - | 149.8 | - | 149.9 | - |
| 9″ | 111.2 | 4.52 s | 111.1 | 4.54 br s | 111.1 | 4.61 br s |
| 10″ | 19.1 | 1.64 s | 19.2 | 1.65 s | 19.1 | 1.72 s |
| OMe | 55.9 | 3.82 s | - | - | - | - |
| OMe | 55.9 | 3.83 s | - | - | 56.1 | 3.91 |
| α | - | - | - | - | 125.4 | 7.95 d (16.0) |
| β | - | - | - | - | 139.8 | 8.02 d (16.0) |
| γ | - | - | - | - | 194.8 | - |
Figure 2Key HMBC correlations of 1.
Figure 3Selected HMBC correlations of 3.
Figure 4Calculated ECD and experimental CD spectra of 1.
Figure 5Calculated ECD and experimental CD spectra of 2.
Figure 6Calculated ECD and experimental CD spectra of 3.
Antimicrobial activities of compounds 1–10 (IC90: μg/mL).
| Compd. |
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
| 8 | 8 | 8 | >256 | 8 | 8 | 16 | 48.0 |
|
| 1 | 1 | 1 | >256 | 1 | 8 | 1 | >50 |
|
| 8 | 8 | 8 | 4 | 8 | 8 | 16 | >50 |
|
| 32 | 32 | 16 | 128 | 32 | 32 | 32 | 6.0 |
|
| >256 | >256 | >256 | >256 | >256 | >256 | >256 | 11.1 |
|
| >256 | >256 | >256 | 128 | >256 | >256 | >256 | >50 |
|
| >256 | >256 | >256 | >256 | >256 | >256 | >256 | >50 |
|
| >256 | >256 | >256 | >256 | >256 | >256 | >256 | >50 |
|
| >256 | >256 | >256 | >256 | >256 | >256 | >256 | >50 |
|
| 32 | nt | nt | 128 | nt | nt | 64 | >50 |
| Strep | 256 | 256 | 128 | 32 | 256 | 128 | nt | nt |
| Cyclohex | nt | nt | nt | nt | nt | nt | 32 | nt |
Strep: Streptomycin; Cyclohex: Cyclohexamide; nt: not tested.
Cytotoxic activity of compounds 1–10 (IC50: μg/mL).
| Compd | KB | Hep-G2 | Lu-1 | MCF-7 |
|---|---|---|---|---|
|
| 59.7 | 32.0 | 80.0 | 71.7 |
|
| 118.4 | >128 | >128 | >128 |
|
| >128 | >128 | >128 | >128 |
|
| 4.8 | 2.27 | 4.0 | 14.5 |
|
| 2.0 | 2.0 | 4.8 | 11.8 |
|
| 47.3 | 78.4 | 71.5 | 60.0 |
|
| >128 | 56.0 | >128 | >128 |
|
| >128 | >128 | >128 | >128 |
|
| >128 | >128 | >128 | >128 |
| Ellipticine | 0.3 ± 0.05 | 0.3 ± 0.05 | 0.4 ± 0.05 | 0.5 ± 0.05 |